Tri-sprintec
Product Images NDC 66116-436

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tri-sprintec (NDC 66116-436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formulas For Norgestimate And Ethinyl Estradiol (Cbcb4427 7a99 467c 915f A8b4c90e2832 01)

Structural Formulas For Norgestimate And Ethinyl Estradiol (Cbcb4427 7a99 467c 915f A8b4c90e2832 01)
This is a medication name likely used in the treatment of hormonal conditions. It is a combination of two active ingredients: norgestimate and ethinyl estradiol. Further information about the medication's indications, dosage, and precautions is not available.*
FDA Label Image

Table Iii (Cbcb4427 7a99 467c 915f A8b4c90e2832 02)

FDA Label Image

Trisprintec Tablets (Cbcb4427 7a99 467c 915f A8b4c90e2832 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.